Valiant Laboratories has approved an investment of up to ₹70 lakh to acquire shares in AMPYR Renewable Energy Resources Twelve A Private Limited. The board sanctioned the move on September 17, 2026, to secure renewable energy for its Tarapur plant.

The acquisition aims to enable the company to procure solar power under a group captive open access arrangement, as permitted by the Electricity Act, 2003. Valiant Laboratories will not gain control or management rights over the target entity.

Transaction Details

The target entity, AMPYR Renewable Energy Resources Twelve A Private Limited, operates a solar power project at Mhasale in Maharashtra. It is a subsidiary of AMPYR India Asset Holdings Two Pte. Ltd., Singapore.

The transaction is structured as a cash purchase from existing shareholders. Valiant Laboratories expects to complete the acquisition upon execution of definitive agreements, including a Share Purchase Agreement and Power Delivery Agreement.

Target Entity Financials

AMPYR Renewable Energy commenced commercial operations on May 27, 2025. Consequently, it reported no turnover in FY24 or FY25. As on March 31, 2026, the entity recorded a turnover of ₹23.26 crore and a net worth of ₹9.99 crore.

The board confirmed that the acquisition does not constitute a related party transaction. Promoters and group companies hold no interest in the target entity. No governmental approvals are required beyond standard corporate compliances under the Companies Act, 2013.

Valiant Laboratories dispatched physical letters on September 3, 2026, to shareholders who have not registered their email addresses. The correspondence provides access to the Annual Report for FY26 and the Notice for the fifth Annual General Meeting scheduled for September 28, 2026.

The company notified the BSE and NSE regarding this dispatch under Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This action ensures that all members, including those without digital contact details, receive information about the upcoming gathering.

Meeting Logistics

Valiant Laboratories will hold its fifth Annual General Meeting on September 28, 2026, at 11:30 am via Video Conferencing or Other Audio Visual Means. The company previously notified exchanges on August 31, 2026, about these logistics. Shareholders with registered emails received the documents electronically.

Physical letters were sent to members as on August 28, 2026, who lacked registered emails with the company, MUFG Intime India Private Limited, or their Depository Participants. These letters contain a web-link to access the documents on the company’s website.

Document Access and Updates

Members can access the Annual Report and AGM Notice through the following path on the company website: www.valiantlabs.in > Investors > Financial Information > Annual Report > Annual Report 2026. The documents are also available on the BSE and NSE portals.

Shareholders holding shares in physical mode are requested to submit KYC forms to MUFG Intime India Private Limited to register their email addresses. Those with demat shares should update their details with their Depository Participants.

Voting Procedures

National Securities Depository Limited is facilitating remote e-voting for the meeting. Shareholders can cast votes on all resolutions either remotely or during the meeting. Queries regarding the voting process can be directed to NSDL at evoting@nsdl.co.in .